Calvin Chao, MD, MBA

Calvin Chao, MD, MBA, Vice President of Medical Science at Artera, is a medical executive with expertise spanning oncology, molecular diagnostics, artificial intelligence, and medical affairs. At Artera, he leads medical strategy and supports the development and clinical integration of AI-enabled biomarker platforms designed to advance precision oncology. Before joining Artera, Chao held leadership positions at Tempus and Genomic Health, where he contributed to medical affairs, cancer diagnostics, and the development and launch of diagnostic products across multiple markets. His background in medicine, business, and engineering enables him to work across clinical, scientific, and commercial disciplines, connecting emerging technologies with clinical practice and the broader requirements of healthcare delivery.